Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Canadian Journal of Gastroenterology & Hepatology|June 2, 2026
Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's DiseaseAgata Michalak, Iwona Zawada, Anna Deskur, et al.
BMC Medical Genomics|January 7, 2017
A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patientsAgnieszka Paziewska, Andrzej Habior, Agnieszka Rogowska, et al.
United European Gastroenterology Journal|January 4, 2025
European Guideline on Chronic Nausea and Vomiting-A UEG and ESNM Consensus for Clinical ManagementCarolina Malagelada, Jutta Keller, Daniel Sifrim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2014
A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancerRandall E Brand, Alex T Adai, Barbara A Centeno, et al.
United European Gastroenterology Journal|May 3, 2021
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsiaLucas Wauters, Ram Dickman, Vasile Drug, et al.
Neurogastroenterology and Motility|September 29, 2021
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsiaLucas Wauters, Ram Dickman, Vasile Drug, et al.
The Lancet. Gastroenterology & Hepatology|August 19, 2017
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept studyDavid Jones, Pol F Boudes, Mark G Swain, et al.
European Journal of Human Genetics : EJHG|January 7, 2016
The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among EuropeansJessica Becker, Stephan L Haas, Anna Mokrowiecka, et al.
Pageof 9